The company has an extensive IP portfolio, valid through 2040, and a drug pipeline in different preclinical and clinical stages, tar ...

Regenerative medicine has the potential to reshape how we treat diseases, offering new hope for patients requiring cell, ...

With over 18 years of experience assisting over 500 client partners and a sizable family of 70+ trusted brands, IBN has ...

Therefore, autoimmune liver diseases are presently treated by suppression of the immune response ... and interferon for hepatitis C virus. For drug-induced liver injury or alcohol-related liver ...

HIV cases and AIDS-related deaths are declining globally, thanks to advanced prevention tools, effective treatments, and ...

Kairos Pharma (NYSE American: KAPA) is a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics. The compan ...

Telangana: Drugs Control Administration, Telangana conducted raids on clinics operated by quacks and seized illegally stocked ...

The FDA has granted LBL-024 orphan drug designation (ODD) for the treatment of neuroendocrine cancer. The agent has already ...

Findings indicate a serine/glycine-free diet can reduce colorectal cancer growth and enhance immune response, offering ...

Kairos Pharma (KAPA) has selected IBN to spearhead its corporate communications efforts. Kairos Pharma’s development pipeline targets drug resistance and immune suppression, two critical barriers to ...

Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.